OA08822A - Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant. - Google Patents
Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.Info
- Publication number
- OA08822A OA08822A OA59308A OA59308A OA08822A OA 08822 A OA08822 A OA 08822A OA 59308 A OA59308 A OA 59308A OA 59308 A OA59308 A OA 59308A OA 08822 A OA08822 A OA 08822A
- Authority
- OA
- OAPI
- Prior art keywords
- morpholine
- pharmaceutical compositions
- preparation process
- compositions containing
- new derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Control For Baths (AREA)
- Earth Drilling (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8704047A FR2612926B1 (fr) | 1987-03-24 | 1987-03-24 | Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA08822A true OA08822A (fr) | 1989-03-31 |
Family
ID=9349348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA59308A OA08822A (fr) | 1987-03-24 | 1988-03-24 | Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4782054A (de) |
| EP (1) | EP0286495B1 (de) |
| JP (1) | JPH0657709B2 (de) |
| AT (1) | ATE89281T1 (de) |
| AU (1) | AU600209B2 (de) |
| CA (1) | CA1313870C (de) |
| DE (1) | DE3880874T2 (de) |
| DK (1) | DK171580B1 (de) |
| ES (1) | ES2006390A6 (de) |
| FR (1) | FR2612926B1 (de) |
| GR (1) | GR1000241B (de) |
| HK (1) | HK57297A (de) |
| IE (1) | IE61882B1 (de) |
| NZ (1) | NZ223984A (de) |
| OA (1) | OA08822A (de) |
| PT (1) | PT87061B (de) |
| ZA (1) | ZA882107B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2653999A1 (fr) * | 1989-11-06 | 1991-05-10 | Adir | Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
| US6048859A (en) * | 1992-06-29 | 2000-04-11 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
| US5637699A (en) * | 1992-06-29 | 1997-06-10 | Merck & Co., Inc. | Process for preparing morpholine tachykinin receptor antagonists |
| US5719147A (en) * | 1992-06-29 | 1998-02-17 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
| IL112778A0 (en) * | 1994-03-04 | 1995-05-26 | Merck & Co Inc | Substituted heterocycles, their preparation and pharmaceutical compositions containing them |
| EP1745029A1 (de) * | 2004-04-30 | 2007-01-24 | Warner-Lambert Company LLC | Substituierte morpholinverbindungen zur behandlung von erkrankungen des zentralen nervensystems |
| GB0409744D0 (en) * | 2004-04-30 | 2004-06-09 | Pfizer Ltd | Novel compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1138405A (en) * | 1966-12-28 | 1969-01-01 | Ici Ltd | Morpholine derivatives |
| BE758766A (fr) * | 1969-11-17 | 1971-05-10 | Ici Ltd | Nouveaux derives de la morpholine et de la |
-
1987
- 1987-03-24 FR FR8704047A patent/FR2612926B1/fr not_active Expired
-
1988
- 1988-03-04 US US07/164,103 patent/US4782054A/en not_active Expired - Lifetime
- 1988-03-09 CA CA000561016A patent/CA1313870C/fr not_active Expired - Fee Related
- 1988-03-18 DK DK150088A patent/DK171580B1/da not_active IP Right Cessation
- 1988-03-23 GR GR880100179A patent/GR1000241B/el not_active IP Right Cessation
- 1988-03-23 AT AT88400693T patent/ATE89281T1/de active
- 1988-03-23 EP EP88400693A patent/EP0286495B1/de not_active Expired - Lifetime
- 1988-03-23 PT PT87061A patent/PT87061B/pt not_active IP Right Cessation
- 1988-03-23 IE IE85188A patent/IE61882B1/en not_active IP Right Cessation
- 1988-03-23 AU AU13520/88A patent/AU600209B2/en not_active Ceased
- 1988-03-23 DE DE88400693T patent/DE3880874T2/de not_active Expired - Fee Related
- 1988-03-23 NZ NZ223984A patent/NZ223984A/xx unknown
- 1988-03-23 JP JP63069198A patent/JPH0657709B2/ja not_active Expired - Lifetime
- 1988-03-24 OA OA59308A patent/OA08822A/xx unknown
- 1988-03-24 ZA ZA882107A patent/ZA882107B/xx unknown
- 1988-03-24 ES ES8800903A patent/ES2006390A6/es not_active Expired
-
1997
- 1997-05-01 HK HK57297A patent/HK57297A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ223984A (en) | 1990-05-28 |
| AU600209B2 (en) | 1990-08-02 |
| CA1313870C (fr) | 1993-02-23 |
| DE3880874D1 (de) | 1993-06-17 |
| PT87061B (pt) | 1992-07-31 |
| JPH0657709B2 (ja) | 1994-08-03 |
| EP0286495B1 (de) | 1993-05-12 |
| US4782054A (en) | 1988-11-01 |
| GR1000241B (el) | 1992-05-12 |
| PT87061A (pt) | 1988-04-01 |
| ZA882107B (en) | 1989-06-28 |
| ES2006390A6 (es) | 1989-04-16 |
| AU1352088A (en) | 1988-09-22 |
| DK150088D0 (da) | 1988-03-18 |
| ATE89281T1 (de) | 1993-05-15 |
| DE3880874T2 (de) | 1993-12-23 |
| IE880851L (en) | 1988-09-24 |
| GR880100179A (en) | 1989-01-31 |
| DK150088A (da) | 1988-09-25 |
| HK57297A (en) | 1997-05-09 |
| JPS63255279A (ja) | 1988-10-21 |
| EP0286495A1 (de) | 1988-10-12 |
| FR2612926B1 (fr) | 1989-06-09 |
| IE61882B1 (en) | 1994-11-30 |
| FR2612926A1 (fr) | 1988-09-30 |
| DK171580B1 (da) | 1997-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS444985A2 (en) | Method of substituted imidazo-(1,5-a)pyridine derivatives production | |
| DE3775882D1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
| JPS56167670A (en) | 1-piperazino-3-phenylindane derivative, its manufacture, pharmaceutical composition and piperazine derivative for manufacture | |
| OA08822A (fr) | Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant. | |
| DE3063288D1 (en) | Paromomycin derivatives, a process for the preparation thereof and therapeutical composition containing them | |
| OA09121A (fr) | Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant. | |
| OA08854A (fr) | Nouveaux dérivés du spiro (4,5) décane, leur procédé de préparation et les compositions pharmaceutiques les renfermant. | |
| FR2703048B1 (fr) | Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant. | |
| OA09467A (fr) | Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant. | |
| OA09451A (fr) | "Nouveaux dérivés de la pyrrolidone, leur procédé de préparation et les compositions pharmaceutiques les renfermant". | |
| HUT48464A (en) | Process for producing pharmaceutical composition for treating hypertonia and cardiac failure | |
| FI891155A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroisotiatsolo/4,5-c/pyridiini-johdannaisten ja niiden isomeerien ja happoadditiosuolojen valmistamiseksi | |
| IL85229A0 (en) | Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,pharmaceutical compositions containing same,and the use thereof | |
| DE3680893D1 (de) | Pyrimido(5,4-b)(1,4)oxazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie zwischenprodukte darstellende pyrimido(5,4-b)(1,4)oxazinderivate. | |
| FR2711651B1 (fr) | Nouveaux analogues cyclisés de métabolites d'acides gras, leur procédé de préparation et les compositions pharmaceutiques les renfermant. | |
| PT86422A (fr) | Procede de preparation de derives d:acide dibenzo]be"-oxepine-acetique et de compositions pharmaceutiques les contenant |